|
| | Terazosin hydrochloride Basic information |
| Product Name: | Terazosin hydrochloride | | Synonyms: | Tarazosin Hydrochloride;[4-(4-Amino-6,7-dimethoxy-quinazolin-2-yl)piperazin-1-yl]-tetrahydrofuran-2-yl-methanone hydrochloride;Methanone,[4-(4-aMino-6,7-diMethoxy-2-quinazolinyl)-1-piperazinyl](tetrahydro-2-furanyl)-,hydrochloride (1:1);abbott-45975;piperazine,1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)c;TERAZOSIN HCL;TERAZOSIN HYDROCHLORIDE;TERAZOSIN MONOHYDROCHLORIDE | | CAS: | 63074-08-8 | | MF: | C19H26ClN5O4 | | MW: | 423.9 | | EINECS: | | | Product Categories: | Terazosin;(intermediate of levofloxacin);Adrenoceptor;Pharmaceutical | | Mol File: | 63074-08-8.mol |  |
| | Terazosin hydrochloride Chemical Properties |
| Melting point | 261-263°C | | storage temp. | Inert atmosphere,2-8°C | | solubility | H2O: 25 mg/mL | | form | powder | | color | white to off-white | | Water Solubility | Soluble in water at 20mg/ml. Also soluble in methanol or ethanol. | | Stability: | Stable for 2 years as supplied. Solutions in distilled water may be stored at -20° for up to 3 months. | | CAS DataBase Reference | 63074-08-8(CAS DataBase Reference) |
| | Terazosin hydrochloride Usage And Synthesis |
| Description | Terazosin hydrochloride is a highly water-soluble antihypertensive agent with a
structure and profile closely related to that of prazosin. | | Originator | Abbott (USA) | | Uses | An α-1-adrenergicblocker related to prazosin. | | Uses | Hytrin (Abbott). | | Uses | Terazosin hydrochloride has been used for orthogonality and similarity analysis using reversed-phase chromatographic studies5. Furthermore, terazosin has also been used for the evaluation of chemometric techniques to determine orthogonality and similarity in chromatographic methods6. | | Brand name | Terazosin
is INN and BAN;HEITRIN. | | General Description | Terazosin hydrochloride, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(tetrahydro-2-furoyl)piperazine monohydrochloride (Hytrin), is a structuralcongener of prazosin hydrochloride. It possessessimilar selective properties of specifically inhibiting 1-adrenergic receptors. The drug is slightly less potent thanprazosin hydrochloride. Terazosin hydrochloride has a halflifeof approximately 12 hours, which is much longer thanthat of prazosin. This lends itself to a once-daily dose tocontrol hypertension in many patients. | | Biological Activity | α 1 - and α 2B -adrenoceptor antagonist (K i values are 3.3, 0.7, 1.1, 7.7, 1510 and 78.2 nM for α 1A , α 1B , α 1D , α 2B , α 2A and α 2C receptors respectively). Antihypertensive following oral or intravenous administration in vivo . | | Biochem/physiol Actions | α1-adrenoceptor antagonist. | | storage | Store at RT | | References | References/Citations
1) Hancock et al. (1995), Actions of terazosin and its enantiomers at subtypes of alpha-1 and alpha-2 adrenoceptors in vitro; Recept. Signal Transduct. Res., 15 863
2) Kyncl et al. (1986), Pharmacology of terazosin; Am. J. Med., 80 12
3) Shionoiri et al. (1994), Long-term therapy with terazosin may improve glucose and lipid metabolism in hypertensives: a multicenter prospective study; Am. J. Med. Sci., 307 Suppl 1 S91
4) Pan et al. (2003), Identification of apoptotic and antiangiogenic activities of terazosin in human prostate cancer and endothelial cells; J. Urol., 169 724
5) Chen et al. (2015), Terazosin activates Pgk1 and HSP90 to promote stress resistance; Nat. Chem. Biol., 11 19 |
| | Terazosin hydrochloride Preparation Products And Raw materials |
|
